trandolapril and Anemia--Hemolytic

trandolapril has been researched along with Anemia--Hemolytic* in 1 studies

Other Studies

1 other study(ies) available for trandolapril and Anemia--Hemolytic

Article	Year
High-dose verapamil + trandolapril-induced thrombotic microangiopathy. Haematologia, 2002, Volume: 32, Issue:3 Thrombotic microangiopathy (TMA) is a syndrome characterized by microangiopathic haemolytic anaemia, thrombocytopenia, and several variable signs of organ damage due to the platelet thrombi in the microcirculation. This article reports a case with TMA which developed after ingestion of a high-dose combination of verapamil and trandolapril. To the authors' knowledge, no prior cases of TMA induced by trandolapril (an angiotensin-converting enzyme inhibitor) and verapamil (a calcium channel blocker) have been reported in the literature. Topics: Adult; Anemia, Hemolytic; Blood Cell Count; Drug Overdose; Female; Hematocrit; Hemoglobins; Humans; Indoles; Microcirculation; Thrombocytopenia; Time Factors; Verapamil	2002

Article

Year

High-dose verapamil + trandolapril-induced thrombotic microangiopathy.

Haematologia, 2002, Volume: 32, Issue:3

Thrombotic microangiopathy (TMA) is a syndrome characterized by microangiopathic haemolytic anaemia, thrombocytopenia, and several variable signs of organ damage due to the platelet thrombi in the microcirculation. This article reports a case with TMA which developed after ingestion of a high-dose combination of verapamil and trandolapril. To the authors' knowledge, no prior cases of TMA induced by trandolapril (an angiotensin-converting enzyme inhibitor) and verapamil (a calcium channel blocker) have been reported in the literature.

Topics: Adult; Anemia, Hemolytic; Blood Cell Count; Drug Overdose; Female; Hematocrit; Hemoglobins; Humans; Indoles; Microcirculation; Thrombocytopenia; Time Factors; Verapamil

2002